- Adalimumab in dermatology2018 | Faculty of Medicine in Pilsen
- The Adalimumab2008 | First Faculty of Medicine
- New biosimilar adalimumab - Hyrimoz(R)2018 | Second Faculty of Medicine
- Adalimumab in the treatment of pediatric psoriasis2016 | First Faculty of Medicine
- Current status adalimumab treatment of Crohn's disease in children2015 | Second Faculty of Medicine
- Role of adalimumab in therapy of autoimmune diseases2016 | First Faculty of Medicine
- Adalimumab in rheumatologic diagnoses2018 | First Faculty of Medicine
- Biosimilar adalimumab in clinical practice2020 | First Faculty of Medicine
- Adalimumab as a choice in the treatment of psoriasis and its possible manifestations2015 | Third Faculty of Medicine
- Successful treatment with adalimumab in a patient with psoriasis, acne and sacroiliitis2023 | First Faculty of Medicine
- First clinical experience with biosimilar adalimumab FKB327 in patients with inflammatory bowel disease2020 | First Faculty of Medicine
- Efficacy and safety of adalimumab therapy in the treatment of ankylosing spondylitis2017 | Publication without faculty affiliation
- Switch from original to biosimilar adalimumab SB-5 in patients with Crohn's disease - long-term results2021 | First Faculty of Medicine
- Biological therapy of inflammatory bowel diseases with adalimumab2019 | First Faculty of Medicine
- New indicaions for adalimumab.2005 | First Faculty of Medicine
- Adalimumab in uveitis therapy2018 | First Faculty of Medicine
- Psoriasis - overwiew of the disease and indications for the biological treatment. Our experiences with adalimumab treatment2020 | Faculty of Medicine in Hradec Králové
- Early adalimumab treatment in RAPublication without faculty affiliation
- Successful adalimumab treatment of severe forms of hidradenitis suppurativa2017 | First Faculty of Medicine
- Adalimumab in the treatment of rheumatoid arthritis2003 | First Faculty of Medicine
- Cost-savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real-world cohort2019 | Faculty of Medicine in Pilsen
- Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial2013 | Faculty of Medicine in Pilsen
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis2008 | First Faculty of Medicine
- Successful Treatment of Severe Hidradenitis Suppurativa with Adalimumab2011 | Third Faculty of Medicine
- An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals2013 | Faculty of Medicine in Pilsen
- Efficacy of the first and subsequent treatment lines with adalimumab in patients with rheumatoid arthritis: data analysis from the Czech National Registry ATTRA2016 | Publication without faculty affiliation
- Psoriasis Treatment with Adalimumab in Clinical Practice: Long Tenn Experience of a Center for Biological Therapy of Psoriasis2015 | Third Faculty of Medicine
- The Influence of Long Term Therapy with Adalimumab on Biomarkers of Systemic Inflammation in Psoriasis2021 | Third Faculty of Medicine
- Point-of-care method for measuring infliximab and adalimumab trough levels in inflammatory bowel disease patients on biologic therapy2022 | First Faculty of Medicine, Central Library of Charles University
- Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study2020 | Faculty of Medicine in Pilsen